Analysis of riociguat and desmethyl riociguat by UPLC-MS/MS and its interaction with quercetin
Riociguat, an orally soluble guanylate cyclase (sGC)-promoting drug, is mainly used in the clinical treatment of pulmonary hypertension (PH). In this study, a novel ultra-performance liquid chromatography-tandem mass spectrometry method was developed to quantify the concentrations of riociguat and i...
Saved in:
Main Authors: | Qingqing Li (Author), Xiaohai Chen (Author), Siping Zhang (Author), Wanshu Li (Author), Hangjuan Lin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a UPLC-MS/MS method for the determination of lacosamide and its metabolite and its application to drug-drug interaction
by: Jie Chen, et al.
Published: (2023) -
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
by: Lian TY, et al.
Published: (2017) -
Treatment of patients with chronic thrombo­embolic pulmonary hypertension: focus on riociguat
by: Smith ZR, et al.
Published: (2016) -
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
by: Igor A. Zupanets, et al.
Published: (2019) -
Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
by: Yu-Yang Liu, et al.
Published: (2023)